Charles Schwab Investment Management Inc. grew its holdings in Owens & Minor, Inc. (NYSE:OMI – Free Report) by 10.2% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,028,236 shares of the company’s stock after purchasing an additional 187,079 shares during the quarter. Charles Schwab Investment Management Inc. owned about 2.63% of Owens & Minor worth $31,823,000 as of its most recent SEC filing.
A number of other institutional investors have also bought and sold shares of the business. Price T Rowe Associates Inc. MD raised its position in shares of Owens & Minor by 5.9% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 48,286 shares of the company’s stock valued at $1,339,000 after buying an additional 2,671 shares during the period. Public Employees Retirement System of Ohio acquired a new position in shares of Owens & Minor during the first quarter worth $120,000. Linden Thomas Advisory Services LLC grew its stake in shares of Owens & Minor by 10.2% during the second quarter. Linden Thomas Advisory Services LLC now owns 19,142 shares of the company’s stock worth $258,000 after purchasing an additional 1,764 shares in the last quarter. Allspring Global Investments Holdings LLC grew its stake in shares of Owens & Minor by 100.6% during the second quarter. Allspring Global Investments Holdings LLC now owns 6,071 shares of the company’s stock worth $82,000 after purchasing an additional 3,044 shares in the last quarter. Finally, Zurcher Kantonalbank Zurich Cantonalbank grew its stake in shares of Owens & Minor by 11.9% during the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 15,364 shares of the company’s stock worth $207,000 after purchasing an additional 1,630 shares in the last quarter. 98.04% of the stock is owned by hedge funds and other institutional investors.
Wall Street Analysts Forecast Growth
OMI has been the subject of a number of analyst reports. Robert W. Baird lowered their target price on shares of Owens & Minor from $19.00 to $14.00 and set a “neutral” rating for the company in a research note on Tuesday, November 5th. JPMorgan Chase & Co. lowered their target price on shares of Owens & Minor from $22.00 to $18.00 and set an “underweight” rating for the company in a research note on Wednesday, August 21st. Citigroup lowered their target price on shares of Owens & Minor from $21.00 to $18.50 and set a “buy” rating for the company in a research note on Tuesday, November 5th. StockNews.com cut shares of Owens & Minor from a “buy” rating to a “hold” rating in a research report on Monday, August 26th. Finally, UBS Group reduced their target price on shares of Owens & Minor from $28.00 to $25.00 and set a “buy” rating for the company in a report on Tuesday, November 5th. Two investment analysts have rated the stock with a sell rating, five have assigned a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $18.50.
Insiders Place Their Bets
In other news, CFO Jonathan A. Leon sold 5,282 shares of the stock in a transaction that occurred on Thursday, November 21st. The shares were sold at an average price of $11.82, for a total value of $62,433.24. Following the sale, the chief financial officer now directly owns 130,822 shares in the company, valued at $1,546,316.04. This represents a 3.88 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 2.62% of the stock is currently owned by company insiders.
Owens & Minor Stock Up 1.7 %
NYSE OMI opened at $14.34 on Wednesday. Owens & Minor, Inc. has a 52-week low of $11.42 and a 52-week high of $28.35. The firm has a 50-day moving average price of $13.48 and a 200 day moving average price of $14.93. The company has a debt-to-equity ratio of 2.11, a current ratio of 1.09 and a quick ratio of 0.45.
Owens & Minor (NYSE:OMI – Get Free Report) last issued its earnings results on Monday, November 4th. The company reported $0.42 earnings per share for the quarter, topping the consensus estimate of $0.41 by $0.01. Owens & Minor had a negative net margin of 0.46% and a positive return on equity of 14.60%. The company had revenue of $2.72 billion for the quarter, compared to analyst estimates of $2.68 billion. During the same period in the prior year, the business posted $0.44 earnings per share. The firm’s revenue for the quarter was up 5.0% compared to the same quarter last year. On average, equities research analysts predict that Owens & Minor, Inc. will post 1.49 earnings per share for the current fiscal year.
Owens & Minor Company Profile
Owens & Minor, Inc, together with its subsidiaries, operates as a healthcare solutions company worldwide. It operates through Products & Healthcare Services and Patient Direct segments. The Products & Healthcare Services segment offers a portfolio of products and services to healthcare providers and manufacturers.
Recommended Stories
- Five stocks we like better than Owens & Minor
- Most Volatile Stocks, What Investors Need to Know
- Beyond NVIDIA: Top 5 Semiconductor Stocks to Watch for 2025
- What Are Some of the Best Large-Cap Stocks to Buy?
- Netflix Is On Track To Hit $1,000 By Christmas
- Differences Between Momentum Investing and Long Term Investing
- UMAC Stock Climbs Amid Trump Jr. Appointment and Meme Stock Hype
Want to see what other hedge funds are holding OMI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Owens & Minor, Inc. (NYSE:OMI – Free Report).
Receive News & Ratings for Owens & Minor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Owens & Minor and related companies with MarketBeat.com's FREE daily email newsletter.